The Dow Jones closed higher by around 65 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Capricor Therapeutics
- The Trade: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Director David Musket acquired a total of 5,083 shares an average price of $2.82. To acquire these shares, it cost around $14,334.
- What’s Happening: Capricor Therapeutics announced late-breaking presentations at 28th Annual Congress of the World Muscle Society.
- What Capricor Therapeutics Does: Capricor ...